An innovative hybrid modeling approach for simultaneous prediction of cell culture process dynamics and product quality

Author:

Polak Jakub1,Huang Zhuangrong2ORCID,Sokolov Michael1,von Stosch Moritz1,Butté Alessandro1,Hodgman C. Eric2ORCID,Borys Michael2,Khetan Anurag2

Affiliation:

1. DataHow AG Zurich Switzerland

2. Biologics Development Global Product Development and Supply Bristol Myers Squibb Devens Massachusetts USA

Abstract

AbstractThe use of hybrid models is extensively described in the literature to predict the process evolution in cell cultures. These models combine mechanistic and machine learning methods, allowing the prediction of complex process behavior, in the presence of many process variables, without the need to collect a large amount of data. Hybrid models cannot be directly used to predict final product critical quality attributes, or CQAs, because they are usually measured only at the end of the process, and more mechanistic knowledge is needed for many classes of CQAs. The historical models can instead predict the CQAs better; however, they cannot directly relate manipulated process parameters to final CQAs, as they require knowledge of the process evolution. In this work, we propose an innovative modeling approach based on combining a hybrid propagation model with a historical data‐driven model, that is, the combined hybrid model, for simultaneous prediction of full process dynamics and CQAs. The performance of the combined hybrid model was evaluated on an industrial dataset and compared to classical black‐box models, which directly relate manipulated process parameters to CQAs. The proposed combined hybrid model outperforms the black‐box model by 33% on average in predicting the CQAs while requiring only around half of the data for model training to match performance. Thus, in terms of model accuracy and experimental costs, the combined hybrid model in this study provides a promising platform for process optimization applications.

Publisher

Wiley

Reference27 articles.

1. U.S. Food and Drug Administration. (2004).Pharmaceutical CGMPs for the 21st Century – A Risk Based Approach; Final Report. U.S. Food and Drug Administration: Silver Spring.

2. Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives

3. ICH Q8 (R2). (2009).Pharmaceutical development ICH Harmonized Tripartite Guidelines.International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.

4. Multivariate PAT solutions for biopharmaceutical cultivation: current progress and limitations

5. Assessment of Recent Process Analytical Technology (PAT) Trends: A Multiauthor Review

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3